R-56865 | Interleukin Related interleukin-related.com

Product Name :
R-56865

Search keywords :
R 56865

drugId :
null

Target Vo:
Sodium channel alpha subunit

Target Vo Short Name :
SCNA

Moa_Name:
Sodium channel alpha subunit blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Myocardial Ischemia

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Oct-4 Rabbit pAb manufacturer
Vunakizumab Epigenetic Reader Domain
ATP Citrate Lyase Antibody (YA829): ATP Citrate Lyase Antibody (YA829) is a non-conjugated and Mouse origined monoclonal antibody about 121 kDa, targeting to ATP Citrate Lyase (3D9). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Monkey.

Author: Interleukin Related

Related Posts